PRTA Q4 2020 Earnings — Prothena Corporation plc Revenue & Financial Results | Market Cap Arena

PRTAProthena Corporation plc

$549M

Q4 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$360,000+40.6% YoY

Gross Profit

-$20M-5666.7% margin

Operating Income

-$30M-8418.9% margin

Net Income

-$31M-8532.2% margin

EPS (Diluted)

$-0.77

QoQ Revenue Growth

+129.3%

Cash Flow

Operating Cash Flow

-$19M

Free Cash Flow

-$19M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$333M

Total Liabilities

$149M

Stockholders' Equity

$184M

Cash & Equivalents

$295M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$360,000	$256,000	+40.6%
Gross Profit	-$20M	-$15M	-34.1%
Operating Income	-$30M	-$23M	-30.2%
Net Income	-$31M	-$22M	-42.5%

Revenue Segments

License

$239,00066%

Collaboration

$121,00034%